# Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment

> **NCT06520878** · PHASE2 · RECRUITING · sponsor: **Distribuidora Biolife SA de CV** · enrollment: 60 (estimated)

## Conditions studied

- Cognition

## Interventions

- **DIETARY_SUPPLEMENT:** NANO-PSO (pomegranate seed oil)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06520878
- **Lead sponsor:** Distribuidora Biolife SA de CV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-12
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520878, "Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06520878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*